Researchers have genetically engineered cells to distract antibodies from attacking friendly, but foreign, cells. This could prevent transplants from being rejected.
Through decades of biobanking at UCSF, researchers were able to comprehensively map intra-cellular signaling in the cells of recurrent glioblastoma, identifying novel cell-extrinsic therapeutic targets.
The California Collaborative for Pandemic Recovery and Readiness Research (CPR3) at UCSF will investigate the effects of the pandemic on California communities and individuals.
In a breakthrough, HT became the first person in the world to receive gene-corrected stem cells for Artemis-SCID. His new immune system is life-changing.
Ten children who were born without functioning immune systems due to Artemis-SCID are now leading healthy lives thanks to a new gene therapy treatment pioneered at UCSF.